Medi-Jector VISION

Base Price

0/5

Medi-Jector VISION

0/5

Manufacturer

Base Price

The Medi-Jector VISION® is a precision needle-free drug delivery system with an advanced design and modern styling, making it smaller, lighter, and less expensive than previous models.

Characteristics
Activities
Conditions
Warnings

Please speak with your healthcare provider and schedule an in-person consultation before purchasing this product, to evaluate whether it is truly the best option for you.

Vendors

evika uses affiliate links when available

Diabetes In Control
Price Not Available
Funding Sources
Medicare (DME MAC)
Medicare is a national health insurance program in the United States, begun in 1965 under the Social Security Administration (SSA) and now administered by the Centers for Medicare and Medicaid Services (CMS). It primarily provides health insurance for Americans aged 65 and older, but also for some younger people with disability status as determined by the SSA, including people with end stage renal disease and amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

HCPCS Code: A4210
Product Category: Nonneedle injection device
Covered Price:

Manufacturer

Antares Pharma

Characteristics

Ergonomic

Activities

Taking Medication

Full Description

The Medi-Jector VISION® is a precision needle-free drug delivery system with an advanced design and modern styling, making it smaller, lighter, and less expensive than previous models. The Medi-Jector VISION® uses pressure to create a micro-thin stream of insulin that penetrates the skin and is deposited into the subcutaneous (fatty) tissue in a fraction of a second. Simple — just dial up the dosage and inject Comfortable — no needle and a quick injection Reliable — because you can clearly see the dose. Average cost for the initial unit with supplies is $395 and supplies for 84 injections cost 30 dollars. They offer a 30-day money back guarantee.

Reviews

There are no reviews yet.

Be the first to review “Medi-Jector VISION”

Your email address will not be published. Required fields are marked *

Loading...